Clinical trial
Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory…
NCT00041561 · Mallinckrodt, Industry · Terminated
Key facts
| NCT number | NCT00041561 |
|---|---|
| Title | Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics |
| Official title | The Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) In Pediatrics |
| Lead sponsor | Mallinckrodt, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Respiratory Insufficiency, Anoxemia |
| Intervention type | Drug |
| Interventions | Nitrogen gas, inhaled nitric oxide |
| Enrollment | 55 |
| Start date | Jan 1, 2002 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Jul 11, 2002 |
| Last update posted | Jul 26, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: